CNS Pharmaceuticals, Inc.
CNSP
$5.52
-$0.60-9.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.96M | -3.22M | -2.38M | -4.30M | -3.18M |
| Total Depreciation and Amortization | 1.00K | 700.00 | 1.10K | 1.10K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.60K | 18.50K | 21.80K | 62.40K | 129.90K |
| Change in Net Operating Assets | 2.82M | 1.03M | -2.99M | 995.90K | -2.43M |
| Cash from Operations | -3.05M | -2.17M | -5.34M | -3.24M | -5.47M |
| Capital Expenditure | -18.20K | -- | -- | -- | -4.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.20K | -- | -- | -- | -4.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.80K | -91.00K | -88.90K | -86.90K | -31.20K |
| Issuance of Common Stock | 501.70K | 800.00 | 4.51M | 9.03M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -64.10K | -1.50K | 0.00 | 882.00K | -10.00K |
| Cash from Financing | 406.90K | -91.60K | 4.43M | 9.83M | 4.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.66M | -2.27M | -917.70K | 6.59M | -511.70K |